Introduction {#S1}
============

In treatment of patients with primary acquired nasolacrimal duct obstruction, external dacryocystorhinostomy (DCR) is the gold standard. DCR was first described by Toti in 1904 as an external approach to the sac through a skin incision in the medial canthus, resecting the adjacent lacrimal sac and nasal mucosa with their intervening bone. In 1921, Dupuy-Dutemps and Bourget, and later Falk et al. in 1961, improved rates of successful fistulization by directly suturing the edges of nasal and lacrimal sac mucosal flaps. For treatment of these patients, alternative techniques to external DCR have been applied such as balloon catheter dilatation, endonasal dacryocystorhinostomy (endonasal DCR) and laser-assisted endonasal DCR. To increase the success rates of these techniques, silicone intubation and application of mitomycin C have been utilized with increased rates of success [@R01]^-^[@R03].

In 1990, Massaro et al. introduced endonasal laser DCR using a high-energy argon laser device and operating microscope [@R04]. Near the end of 1980s with the development of high-resolution fiber-optic endoscopes, satisfactory images were obtained, and as a consequence endonasal and transcanalicular laser DCR techniques were launched [@R04] [@R05]. Transcanalicular laser dacryocystorhinostomy (TLDCR) was first introduced by Levin et al. using cadavers in 1992 [@R06]. Nowadays, various types of laser techniques have been applied that are becoming to be more widely used, and the long-term results are beginning to be reported.

The present study prospectively evaluated long-term surgical success and safety in patients with nasolacrimal duct obstruction treated with multidiode transcanalicular laser and bicanalicular silicone intubation stenting.

Material and methods {#S2}
====================

Study design {#S2a}
------------

The study was approved by the Ethics committee (298/2010). Written informed consent was obtained from all subjects or a legal surrogate. 42 patients treated with TLDCR for nasolacrimal duct obstruction were prospectively enrolled in this non-comparative study. Patients with epiphora, chronic dacryocystitis and dacryostenosis were included. Cases with the presence of intrasaccular adhesions, common canalicular stenosis, acute dacryocystitis, recurrent dacryostenosis, paediatric cases, canalicular stenosis, lacrimal sac neoplasms, dacryolithiasis, fistulous dacryostenoses, predominant bone deformities (posttraumatic or lacrimal sac fossa deformities) and additional intranasal abnormalities were excluded from the study.

Lacrimal system irrigation was applied for all patients presenting with complaints of epiphora. The diagnosis was supported by dacryocystograms obtained after instillation of 480 mg/ml radio-opaque iodine into the sac. Endoscopic examination was performed by otolaryngologists on all patients before surgery.

Surgery was performed under general anaesthesia using a multidiode laser (Intermedical Multidiode S-30 OFT^®^) device. Surgery was performed by two ophthalmologists. Vasoconstriction was achieved by packing the nasal cavity with cotton sponges soaked in 4% lidocaine and epinephrine (1/100,000), which was left in place 10 min before surgery. Canalicular dilatation was performed, and a transcanalicular diode laser probe of 600 μm fiber optic (silicafluopolymer) was inserted. Nasal endoscopy to visually control the tip of the laser probe was performed throughout the procedure. The middle turbinate was infractured medially to enhance access to the lateral wall of the nasal fossa and to protect middle turbinate from laser shots in cases where the middle turbinate was very close to the area of application. The light of the laser probe was transnasally observed, just lateral and superior to the middle turbinate, at the upper third of maxillary line. A 980 nm diode laser was applied through the transcanalicular approach with 500 msec multi-pulse mode at 8-10 W obliterating the overlying nasal mucosa and creating an osteotomy until a size greater than 11 x 4 mm was achieved. Carbonized tissues were removed. The patency of the lacrimal canal was checked with lacrimal irrigation. In addition, the osteotomized region was cleansed with the same irrigation solution. In all cases, bicanalicular silicone stents were inserted. None of the patients received mitomycin C ([Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}).
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All patients were postoperatively monitored during the first few days, then weekly for one months, followed by monthly visits for two months, and then every three months up to 42 months by otolaryngologists, and ophthalmologists. Silicone stents were withdrawn at the second postoperative month. During the first week, oral antibiotic prophylaxis (amoxicillin + clavulanic acid 1000 mg b.i.d.), analgesics, anti-inflammatory drugs (naproxen sodium 550 mg b.i.d.) and topical tobramycin ointment 5 times/day were administered. Topical decongestants (xylometazoline hydrochloride 1 mg b.i.d.) were prescribed post operatively for two days. To avoid potential development of allergic conditions against the silicone tube, and to prevent obstruction of the osteotomized area with inflammatory lesions triggered by allergic reactions, topical steroid nasal sprays (fluoromethalone acetate 0.1% 4 times/day) were used until the silicone tube was removed. To avoid possible side effects such as cataract and glaucoma, fluoromethalone steroids were preferred.

Outcome measures {#S2b}
----------------

At each physical examination, lacrimal irrigations were performed, and patients were queried for the presence of epiphora. Objective outcome measures were obtained by patency testing after lacrimal system irrigation with fluorescein saline. Persistence of the nasolacrimal window was visualized by nasal endoscopy. Osteotomy size was monitored by comparison with the tip of a probe. Cases without epiphora and proven nasal ostium patency demonstrated with free-flow lacrimal irrigation were deemed as successful. Failure was defined as the lack of any improvement in either symptoms or the fluorescein disappearance test.

Statistical analysis {#S2c}
--------------------

Data were analyzed using the Statistical Package for Social Sciences (SPSS) software (version 15.0 for Windows). All differences associated with a chance probability of 0.05 or less were considered statistically significant. Chi-square and student t tests were performed on nominal data.

Results {#S3}
=======

Patients, 10 (24%) males and 32 (76%) females, ranged in age from 19 to 66 years (mean 52.2 ± 10.7). In all cases, involvement was unilateral. 25 cases (59.5%) had involvement of the right eye, and the other 17 had involvement of the left eye. Mean operative time was determined to be 13.4 ± 5.3 (range 9 to 21) minutes.

Lacrimal system was functional in 95.2% of the patients and the osteotomy size was \> 4 mm ([Figs. 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). Age and sex were found to have no statistical significance (p ≥ 0.05). The endocanalicular laser DCR failed in two of the 42 (4.8%) cases. There were no complaints of tearing in the other patients. In the first patient undergoing intervention, common canalicular thermal injury developed due to strayed laser emissions, and common canalicular stenosis developed at the first month. Recurrence at the third month was seen in our second unsuccessful case. In these two patients, successful results were obtained with external DCR and bicanalicular silicone stent intubation. The osteotomized region was monitored using endoscopy. Lacrimal pump syndrome was not seen in any patient.
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Discussion {#S4}
==========

Long-term success rates of laser TCDCR are generally lower than those of external DCR, which is considered to be the \"gold standard\" [@R07]^-^[@R09]. Success rates of external DCR usually range between 85-99%, and are usually greater than 90% [@R10] [@R11]. However, the advantages of laser TCDCR over external DCR are lack of scar development, fewer morbidities, no need for general anaesthesia, diminished perioperative and postoperative bleeding, intact pump mechanism because of unaffected medial canthal tendon and a less invasive procedure. The technique can be easily applied under local anaesthesia. In our study, since we are learning and using this technique for the first time, patients were operated under general anaesthesia. Since we have applied this technique only recently, we did not include paediatric cases in the study because of their narrower intranasal operative field. Patients with intrasaccular adhesions, and common canalicular stenosis as demonstrated with dacryocystography, were also excluded. In these cases, thermal damage can develop in the common canalicular region and posterior wall of the lacrimal sac.

Success rates of 63-91% (mostly \< 85%) have been reported for endonasal DCR technique without the use of laser energy [@R12]^-^[@R14]. When we compared success rates of DCR and laser TCDCR, similar success rates for both techniques were observed. An endonasal approach has been widely used. For such an approach, various instruments such as cold knife, lasers, punches, radiofrequency units and drills are required [@R15] [@R16]. However, endonasal DCR has some disadvantages such as need for greater number of instruments to be used intranasally, orbital perforation and a long learning curve [@R17]. In laser TCDCR, since the laser probe is not directed to the eye orbit, it is possible to avoid orbital perforation. For endonasal laser DCR, success rates ranging between 58-97% (mostly \< 85%) have been reported [@R18]^-^[@R22].

Different success rates have been reported with TCDCR. In the last 10 years, success rates have varied between 59-92%, mostly \< 85 percent [@R23]^-^[@R30]. The success rate in our study was 95.2%. We attribute this difference to the application of this technique on selected cases by two highly experienced surgeons in the external DCR technique. Besides we think that larger sized ostial openings increase success rates. Since the laser probe we used does not require a guide, an appropriate light angle (0.46°) of our transcanalicular probe make creation of a larger ostium possible. In addition, lower energy is used and less tissue damage occurs with this technique.

Laser TCDCR and external DCR are alternative modalities to endonasal DCR. The absence of skin scars, shorter duration of the operation, shorter learning-curve, lack of orbital perforation risks, need for fewer number of instruments, reproducibility of the techniques, better perioperative and postoperative hemostasis, ease of application by the ophthalmologists, earlier rehabilitation, lower morbidity rates and easy applicability under local anaesthesia have made these techniques attractive alternatives. There are certain disadvantages of this procedure, such as handling and cost of the laser, synechia and granulation tissue formation, common canalicular stenosis and low success rate in paediatric patients. However, because of the aforementioned advantages, we believe that success rates will increase in parallel with advancements in instrumentation and increased surgical experience.

Conclusions {#S5}
===========

TLDCR using a multidiode laser is well tolerated in patients unresponsive to medical therapy. Further comparative studies are required to clarify the results of multidiode laser use in patients with nasolacrimal duct obstruction.
